Studies have linked APOE ε4 to increased risk and lower age of onset of frontotemporal dementia (FTD)2–6, Parkinson’s disease (PD)5,7,8 and amyotrophic lateral sclerosis (ALS)9,10. This evidence concerns the gene APOE and amyotrophic lateral sclerosis.